News | Press Releases

For Immediate Release Contact marketingcommunications@us.medical.canon

November 30, 2014

Toshiba’s New Infinix 4DCT Seamlessly Integrates IR and CT into One Solution

Challenges the Status Quo in Minimally Invasive Procedures with Improved Workflow, Accuracy and Safety

As the first seamless integration between Interventional Radiology (IR) and CT technology, Toshiba America Medical Systems, Inc.’s all-new InfinixTM 4DCT provides clinicians with faster, safer and more accurate interventions.

As the first seamless integration between Interventional Radiology (IR) and CT technology, Toshiba America Medical Systems, Inc.’s all-new Infinix 4DCT provides clinicians with faster, safer and more accurate interventions.

CHICAGO, Nov. 30, 2014 – As the first seamless integration between Interventional Radiology (IR) and CT technology, Toshiba America Medical Systems, Inc.’s all-new InfinixTM 4DCT provides clinicians with faster, safer and more accurate interventions. With this innovative combination, healthcare providers can plan, treat and verify in a single clinical setting for better patient care – rather than transferring patients between departments, risking infection and dragging out procedure times.

Toshiba’s Infinix 4DCT maximizes the full potential of IR and CT systems to deliver real-time CT images during interventions instead of CT-like images. The system significantly improves workflow with its SUREGuidance technology (pending 510(k) clearance) that allows for seamless and automatic transition between modalities. And, it is capable of saving hours by allowing clinicians to perform CT and interventional procedures within the same room and verify treatment success immediately after procedures.

Clinically, the system improves workflow of oncology and cardiac procedures. It provides interventionalists with CT images of liver tumors and produces more precise views of the heart and stent placements. Clinicians can also adjust the procedure with real-time studies instead of relying on CT images taken at an earlier time.

“Given the choice, most physicians would want real-time CT images versus CT-like images during complex, minimally invasive procedures,” said David Sloop, director, X-ray Vascular Business Unit, Toshiba. “With the Infinix 4DCT, physicians no longer have to settle; for the first time, they have a seamlessly integrated IR and CT product to improve patient care.”

Toshiba is introducing the Infinix 4DCT at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 30 – Dec. 5, 2014 (Booth #7333, North Hall).  Currently the system is FDA cleared with the Infinix Elite and AquilionTM ONE ViSION Edition configuration. It is (pending 510(k) clearance) for use with the Aquilion PRIME CT system.

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at www.toshibamedicalsystems.com.

About Toshiba

Toshiba Corporation, a Fortune 500 company, channels world-class capabilities in advanced electronic and electrical products and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future,” Toshiba promotes global operations towards securing “Growth Through Creativity and Innovation” and is contributing to the achievement of a world in which people everywhere live in a safe, secure and comfortable society.

Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 590 consolidated companies employing over 200,000 people worldwide, with annual sales surpassing 6.5 trillion yen (US$63 billion). To find out more about Toshiba, visit www.toshiba.co.jp/index.htm.

Infinix, Aquilion, Aquilion ONE, Aquilion ONE ViSION and ViSION Edition are trademarks of Toshiba Medical Systems Corporation.

###